Literature DB >> 9626471

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

K Sonoda1, T Kaku, T Kamura, M Nakashima, T Watanabe, H Nakano.   

Abstract

We have reported that a novel tumor-associated antigen (Ag), 22-1-1, was expressed in cancer cells derived mainly from the uterus and ovary [K. Sonoda et al., Cancer (Phila.), 77: 1501-1509, 1996]. The 22-1-1 Ag existed not only in adenocarcinomas but also in squamous cell carcinomas in the uterine cervix. Here, a relationship between tumor progression and invasion and 22-1-1 Ag expression was investigated in squamous cell neoplasms of the uterine cervix using immunohistochemical staining. The 22-1-1 Ag was not detected in normal uterine cervix (0 of 10 total cases) and dysplasias (0 of 47 total cases). However, 20% of carcinoma in situ (4 of 20 total cases) and 16.7% of microinvasive carcinomas (2 of 12 total cases) stained positively for 22-1-1 Ag. Moreover, areas depicting microinvasion on histology in uterine cancers (stage Ia) were more strongly stained than carcinoma in situ lesions. 22-1-1 Ag expression was found to be more frequent in invasive squamous cell carcinomas (82.6%; 57 of 69 total cases). The 22-1-1 Ag existed both in the cytoplasm and on the membrane of cancer cells. These findings suggest that 22-1-1 Ag expression might be related to tumor cell progression and invasion in the uterine cervical squamous cell epithelium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626471

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  10 in total

1.  RCAS1, a useful serum marker to predict the recurrence of cancer: two cases of cholangiocarcinoma and pancreatic cancer.

Authors:  Munechika Enjoji; Makoto Nakamuta; Koji Yamaguchi; Kazuhiro Kotoh; Shusuke Morizono; Eiichiro Arimura; Marie Fukushima; Masami Kuniyoshi; Manabu Nakashima; Masao Tanaka; Hajime Nawata
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

2.  Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Shinichi Oka; Teruhisa Sakamoto; Shingo Kanaji; Shigeru Tatebe; Masahide Ikeguchi
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

3.  Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer.

Authors:  K Leelawat; T Watanabe; M Nakajima; S Tujinda; C Suthipintawong; V Leardkamolkarn
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

4.  Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis.

Authors:  Yasunobu Abe; Koichi Ohshima; Manabu Nakashima; Keiichi Hara; Takamitsu Matsushima; Ilseung Choi; Junji Nishimura; Masahiro Kikuchi; Hajime Nawata; Takeshi Watanabe; Koichiro Muta
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

5.  Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma.

Authors:  Koichiro Muta; Koichi Ohshima; Yasunobu Abe; Naokuni Uike; Ilseung Choi; Takamitsu Matsushima; Junji Nishimura; Masahiro Kikuchi; Manabu Nakashima; Takeshi Watanabe; Hajime Nawata
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

6.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

Review 7.  Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.

Authors:  Vahideh Keyvani; Espanta Riahi; Meysam Yousefi; Seyed-Alireza Esmaeili; Rana Shafabakhsh; Amin Moradi Hasan-Abad; Maryam Mahjoubin-Tehran; Michael R Hamblin; Samaneh Mollazadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

8.  Association between RCAS1 expression and clinical outcome in uterine endometrial cancer.

Authors:  K Sonoda; S Miyamoto; T Hirakawa; T Kaku; M Nakashima; T Watanabe; K Akazawa; T Fujita; H Nakano
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

9.  Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.

Authors:  J-I Akahira; M Aoki; T Suzuki; T Moriya; H Niikura; K Ito; S Inoue; K Okamura; H Sasano; N Yaegashi
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  A disintegrin and metalloproteinase 9 is involved in ectodomain shedding of receptor-binding cancer antigen expressed on SiSo cells.

Authors:  Kenzo Sonoda; Kiyoko Kato
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.